Evidence map›Paper›PMID 41893823›Full record

ArticleVaccines2026

Correction: Müller et al. Does the Vaccination Against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates Below the WHO Threshold for Endemicity? A Case Study for Germany.

Malina Müller, Hannah Lintener, Vivien Henkel, Andreas Pilz, Kate Halsby, Claudius Malerczyk, Harish Madhava, Jennifer C Moïsi, Holly Yu, Katharina Schley

Abstract readPublished Erratum
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Malina MüllerWifOR Institute, 64283 Darmstadt, Germany.ORCID 0009-0004-4846-2746
Hannah LintenerWifOR Institute, 64283 Darmstadt, Germany.
Vivien HenkelWifOR Institute, 64283 Darmstadt, Germany.
Andreas PilzPfizer Corporation Austria GmbH, 1210 Vienna, Austria.ORCID 0000-0002-6394-3845
Kate HalsbyPfizer Ltd., Tadworth KT20 7 NY, UK.
Claudius MalerczykPfizer Pharma GmbH, 10117 Berlin, Germany.
Harish MadhavaPfizer Ltd., Tadworth KT20 7 NY, UK.
Jennifer C MoïsiPfizer, 75014 Paris, France.
Holly YuPfizer Inc., Collegeville, PA 19426, USA.ORCID 0000-0001-8625-4201
Katharina SchleyPfizer Pharma GmbH, 10117 Berlin, Germany.ORCID 0000-0002-0975-4154

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The authors would like to make the following corrections to this published paper [1] [...].

Identifiers

PMID41893823
PMCPMC13030637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.